JPS57169417A - Agent for suppressing formation of platelet thrombus - Google Patents

Agent for suppressing formation of platelet thrombus

Info

Publication number
JPS57169417A
JPS57169417A JP5501381A JP5501381A JPS57169417A JP S57169417 A JPS57169417 A JP S57169417A JP 5501381 A JP5501381 A JP 5501381A JP 5501381 A JP5501381 A JP 5501381A JP S57169417 A JPS57169417 A JP S57169417A
Authority
JP
Japan
Prior art keywords
agent
compound
formula
salt
active component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5501381A
Other languages
Japanese (ja)
Inventor
Hajime Fujimura
Masakatsu Nozaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiyo Pharmaceutical Industry Co Ltd
Original Assignee
Taiyo Pharmaceutical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiyo Pharmaceutical Industry Co Ltd filed Critical Taiyo Pharmaceutical Industry Co Ltd
Priority to JP5501381A priority Critical patent/JPS57169417A/en
Publication of JPS57169417A publication Critical patent/JPS57169417A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE: To obtain the titled agent having strong platelet coagulation suppressing activity and low side effects, by using 2-[4-(2-thienylcarbonyl)phenyl]propionic acid or its salt as an active component.
CONSTITUTION: The agent contains the compound of formula or its salt as an active component. It is applied in the form of e.g. tablet, capsule, injection, suppository, etc. The compound of formula has strong platelet coagulation suppressing activity and weak effect to inhibit the biosynthesis of PGI2. It is administered usually in doses of preferably 20W100mg, 3 times daily. The agent is effective for the prevention and remedy of cerebral thrombosis, arteriosclerosis, cardiac infarction, etc. The compound of formula is known as an analgesic and antiphlogistic agent.
COPYRIGHT: (C)1982,JPO&Japio
JP5501381A 1981-04-14 1981-04-14 Agent for suppressing formation of platelet thrombus Pending JPS57169417A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5501381A JPS57169417A (en) 1981-04-14 1981-04-14 Agent for suppressing formation of platelet thrombus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5501381A JPS57169417A (en) 1981-04-14 1981-04-14 Agent for suppressing formation of platelet thrombus

Publications (1)

Publication Number Publication Date
JPS57169417A true JPS57169417A (en) 1982-10-19

Family

ID=12986770

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5501381A Pending JPS57169417A (en) 1981-04-14 1981-04-14 Agent for suppressing formation of platelet thrombus

Country Status (1)

Country Link
JP (1) JPS57169417A (en)

Similar Documents

Publication Publication Date Title
JPS5735512A (en) Preventive and remedy for thrombosis
MD523G2 (en) New triazol pyrimidine derivatives, angiotension II antagonist, processes for preparation thereof, pharmaceutical compositions containg thereof
GB9903403D0 (en) Substituted stilbene compounds with vascular damaging activity
JPS5721320A (en) Blood sugar level depressing agent
JPS57169417A (en) Agent for suppressing formation of platelet thrombus
WO1994003425A3 (en) Carbostyril derivatives for the treatment of arrhythmia
WO2002004423A8 (en) Thrombin inhibitors comprising an aminoisoquinoline group
NO170974C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC USE (((((3-PYRIDINYL) METHYLE) AMINO) OXYY) ALKANIC ACIDS AND ESTERS THEREOF AND THE INTERMEDIATE PRODUCT FOR USE IN THE PROCEDURE
JPS5547655A (en) N-substituted derivative of moranoline
JPS57140754A (en) Dihydroxybenzoic acid derivative and physiologically active preparation containing the same
IE781226L (en) Antithrombatic compound
BE900186A (en) SYNERGISTIC FUNGICIDE COMPOSITIONS.
JPS5340742A (en) Prostagilandin analogues, their preparation and medical composition containing the same as active constituents
JPS56152418A (en) Hypoglycemic agent
JPS56115715A (en) Physiologically active agent containing (3- dimethylcarbam-oxyphenyl) trimethyl ammonium derivative
IE782005L (en) Pharmaceutical compositions
JPS57108014A (en) Antithrombotic agent
JPS5750918A (en) Remedy for hyperuricemia
JPS5742620A (en) Novel antiulcer agent
JPS54105237A (en) Analgesic agent containing nalorphine-6-glucuronide
JPS5569512A (en) Antispasmodic agent
JPS5572114A (en) Blood platelet coagulation inhibiting agent containing 3-benzoylpyrrole derivative
JPS5651452A (en) Derivative of acylated indole, its preparation and blood platelet coagulation suppressing agent containing said compound as effective component
JPS57134471A (en) Novel sydnonimine derivative, its preparation, and drug containing said derivative as active component
JPS55167220A (en) Antitumor drug